Benefits
Supports antioxidant defense (preclinical)
In two rat studies from the same research group, tetrahydrocurcumin lowered markers of oxidative damage and raised the activity of the animals' own antioxidant enzymes. Both used rats with chemically induced diabetes. There is no human trial of tetrahydrocurcumin cited on this page, so it is unknown whether any of this happens in people.
Supports anti-inflammatory pathways (preclinical)
One 2007 laboratory study in cultured cells compared curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin, and turmerones, and found they act differently on inflammation-related and cell-growth pathways. That is cell-dish work. No human study has shown that tetrahydrocurcumin reduces inflammation in the body.
More chemically stable than curcumin (a formulation property, not a health benefit)
THC is colorless, more chemically stable, and more water-compatible than the parent curcumin molecule, which degrades at physiological pH. That is a chemistry property, not a health effect. No study cited here shows that the extra stability produces any benefit you would notice.
Studied only in diabetic rats for antioxidant and metabolic markers (preclinical)
The two rat studies cited here looked at antioxidant status and red blood cell membrane enzymes in rats with chemically induced diabetes. Neither measured liver outcomes, and neither involved people. Nothing here shows that tetrahydrocurcumin supports liver or metabolic health in humans.
Mechanism of action
Free-radical scavenging by reduced beta-diketone
The saturated beta-diketone in tetrahydrocurcumin retains hydrogen-donating capacity for direct radical scavenging while removing the conjugated olefinic system of curcumin, contributing to a distinctive antioxidant profile demonstrated in preclinical models.
Modulation of inflammatory transcription factors
Cell-based laboratory studies report that THC affects NF-κB and other inflammatory transcription factors and downstream cytokines such as TNF-α and IL-6, This is what happens in cell cultures. Whether it happens at a meaningful level in the human body has not been tested.
Endogenous gut metabolite of curcumin
THC is the major in vivo reductive metabolite of curcumin generated by gut microbiota and intestinal enzymes; researchers have suggested that some of curcumin's effects may come from THC formed in the gut, which is the idea behind taking THC directly. That idea has not been tested head to head in people.
Clinical trials
Preclinical study in streptozotocin-nicotinamide induced diabetic rats evaluating the antioxidant effects of tetrahydrocurcumin on lipid peroxidation and antioxidant enzyme activity.
Streptozotocin-nicotinamide diabetic rat model; preclinical.
Tetrahydrocurcumin reduced markers of fat damage and improved antioxidant enzyme activity in the rats. This was an animal experiment, not a clinical trial, and it does not tell us what tetrahydrocurcumin does in people.
Mechanistic comparison of curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin, and turmerones on anti-inflammatory and anti-proliferative responses through ROS-independent mechanisms.
Cell-based mechanistic study; preclinical.
Curcumin and related turmeric compounds, including tetrahydrocurcumin, acted differently on inflammation-related and cell-growth pathways, by a route that did not depend on reactive oxygen species. This was done in cultured cells, so it points to a possible mechanism and not to a health effect in people.